News & Events | News

SJ Berwin LLP advises Neurim on the licensing of Circadin® to Lundbeck
11/10/07
SJ Berwin today announced that it has advised Neurim Pharmaceuticals Ltd and Neurim S.A. on the licensing of Circadin® to H.Lundbeck A/S...... Read more

SJ Berwin LLP Advises NicOx S.A on a Major New Agreement with Merck & Co., Inc
31/03/06
SJ Berwin today announced that it has advised NicOx S.A, the emerging pharmaceutical research company listed on Eurolist... Read more

SJ Berwin LLP Advises NicOx S.A on Major Ophthalmology Agreement with Pfizer Inc
27/03/06
SJ Berwin today announced that it has advised NicOx S.A, the emerging pharmaceutical research company listed on Eurolist, on a major agreement with the world's largest pharmaceutical company, Pfizer Inc. The agreement grants Pfizer exclusive rights to certain NicOx technology, across a broad range of eye diseases. Such diseases, some of which currently have no effective treatment, affect millions of people worldwide and can lead to impaired vision or total blindness. ... Read more

SJ Berwin LLP Advises NicOx S.A on Two International Pharmaceutical Agreements
17/11/05
SJ Berwin today announced that it has advised NicOx S.A, the emerging pharmaceutical research company, on two recently concluded international pharmaceutical agreements... Read more

SJ Berwin Advises BioXell on Licence Agreement
26/05/05
SJ Berwin has announced that it advised BioXell, the Italian biopharmaceutical company on its recently concluded exclusive, worldwide licence agreement... Read more

SJ Berwin Advises on £20 Million Biotechnology Spin Out
27/05/04
SJ Berwin advised a syndicate of private equity investors who have supported a £20 million spin out of the needle-free injection technology business from Chiron Vaccines... Read more

SJ Berwin and Foley Hoag Advise TVM on €25 Million Investment in Evotec NeuroSciences
28/04/04
SJ Berwin's Berlin Venture Capital and BioTech team, together with Foley Hoag LLP, Boston, advised TVM Techno Venture Management as lead investor of a consortium of investors on a €25 million first round investment in Evotec NeuroSciences, a subsidiary of publicly listed Evotec EOAI AG. ... Read more

SJ Berwin Advises on £21 Million Investment in Renovo
02/12/02
SJ Berwin has maintained its reputation as one of the leading law firms advising in the global biotechnology/lifescience arena, building upon its impressive record to date... Read more

SJ Berwin Advises NicOx on Development and Licensing Agreement for Chronic Liver Disease Compound
18/06/02
SJ Berwin advised French pharmaceutical company NicOx on a development and licensing agreement with Axcan Pharma for NicOx's compound NCX 1000... Read more

SJ Berwin Advises on £25.5 Million Investment into Leading Biotechnology Company
27/02/02
SJ Berwin has maintained its reputation as one of the leading law firms advising in the global biotechnology/lifescience arena... Read more

SJ Berwin Advises on Investments in Leading Biotechnology Companies
17/10/01
SJ Berwin has confirmed its reputation as one of the leading law firms advising in the global lifescience arena... Read more

SJ Berwin Advises on Investment into Leading Drug Discovery Company
05/07/01
SJ Berwin acted for a syndicate of some of the most respected investors in the global lifescience arena on its equity investment ... Read more